Two companies, APOTEX and GlaxoSmithKline, have issued letters of voluntary recall of the preparation containing Ranitidine Hydrochloride.
The Ministry of Health, out of an abundance of caution to safeguard the population, is issuing an urgent recall of all preparations containing Ranitidine Hydrochloride. This is as a result of the presence of a nitrosamine impurity, N-nitrosodimethylamine (NDMA), above acceptable levels.
The public is advised to return all purchased products to the point of sale IMMEDIATELY. Persons who received the preparations from Public Health Institutions are advised to return these preparations to the pharmacy department of the nearest Public Health Institution. Patients can speak to the health care provider for further information.
Additional information can be obtained by contacting the Office of the Director of Chemistry, Food and Drugs Department at 623-5242 or the Office of the Principal Pharmacist at 625-6049.
The Ministry of Health will continue to monitor the situation and advise the population as necessary.
Meanwhile locally based pharmacy SuperPharm issued a released on their Instagram account advising their customers about the recall and return of medication for a refund.